28.03.2014 • NewsDede WillamsEU shaleIneos

TGE Named Preferred Bidder for Grangemouth Ethane Tank

Ineos has named TGE Gas Engineering as the preferred bidder to build a large ethane tank at Falkirk, Scotland, near its Grangemouth production complex. 

The choice of a contractor for the £125 million, 40-meter-high storage tank capable of holding 33,000 t of liquefied ethane and due for completion in 2016 is being called a "key milestone" in the Swiss-based group's plan to import shale gas from the U.S.  

Local company representatives described the tank, which would be Europe's biggest, as "a crucial part" of the survival plan for the Scottish site, adding that, "by 2016 Grangemouth will be a shale gas based facility, essential for it to become a profitable business again."

The overall investment of £300 million in revamping Grangemouth to operate on light ethane feed is to be supported in part by grants and loans from the UK and Scottish regional governments.

Ineos said its older ethylene cracker and associated butadiene plant will close "with immediate effect," with production to be concentrated at more modern facilities on the same site.

No jobs are now planned to be lost in the reshuffle, which reflects terms of a package agreed with employees after a protracted labor dispute in October 2013. Affected staff are to be redeployed across the site.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read